Abstracts tagged "infection and risk"

Abstract Number: 1004 • 2016 ACR/ARHP Annual Meeting
Herpes Zoster Virus Infection in Patients Treated with Biological Therapies (BIOBADASAR)
Juan Pablo Pirola¹, Soledad Retamozo², Diego Baenas³, Alejandro Alvarellos⁴, Francisco Caeiro⁵, María Celina De La Vega⁶, Gustavo Casado⁷, Gimena Gomez⁸, Javier Roberti⁶, Osvaldo Luis Cerda⁹, Maria de los Angeles Gallardo¹⁰, Ana Quinteros¹¹, Ida Exeni¹², Juan Manuel Bande¹³, Pablo Astesana¹⁴, Analia Alvarez¹⁵, Amelia Granel¹⁶, Alejandra Peluzzon¹⁷, Ana Capuccio¹⁸, Romina Nieto¹⁹, Rossana Quintana²⁰, Eduardo Mussano²¹, Santiago Scarafia²², Carolina Costi²³, Mercedes De La Sota²⁴, Monica Patricia Diaz²⁵, Edson Javier Velozo²⁶, Santiago Aguero²⁷, Cristina Battagliotti²⁸, Sidney Soares de Souza²⁹, Emilia Cavillon³⁰, Analia Bohr³¹, Andrea Smichowski³², Alejandro Benitez³³, Daniela Vidal³⁴, Dora Pereira³⁵, Liliana Martinez³⁶, Luis Somma³⁷, Marta Zalazar³⁸, Pablo Finucci Curi³⁹, Leandro Carlevaris⁴⁰, Guillermo Berbotto⁴¹ and Veronica Saurit¹, ¹Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, ²Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Argentina, Córdoba, Argentina, ³Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, ⁴Rheumatology, Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, ⁵Reumatología, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, ⁶SAR, CABA, Argentina, ⁷Sociedad Argentina de Reumatologia, CABA, Argentina, ⁸Section of Rheumatology an, SAR, CABA, Argentina, ⁹IREP, CABA, Argentina, ¹⁰Hospital Italiano de Buenos Aires, CABA, Argentina, ¹¹Centro Integral Reumatológico, Tucuman, Argentina, ¹²Sanatorio Parque, Córdoba, Argentina, ¹³Hospital Tornú, CABA, Argentina, ¹⁴Sanatorio Allende, Cordoba, Argentina, ¹⁵Hospital Penna, Bahía Blanca, Argentina, ¹⁶Centro Platense de Reumatología, La Plata, Argentina, ¹⁷Hospital Clínica José de San Martín, CABA, Argentina, ¹⁸Hospital Cesar Milstein, CABA, Argentina, ¹⁹Hospital Provincial, Rosario, Argentina, ²⁰Sanatorio Parque, Rosario, Argentina, ²¹Córdoba, Hospital Nacional de Clínicas, Córdoba, Argentina, ²²Hospital Bernardino Rivadavia, CABA, Argentina, ²³Hospital San Martín, LaPlata, Argentina, ²⁴Consultorios, Bahia Blanca, Argentina, ²⁵Hospital Zonal Bariloche, Bariloche, Argentina, ²⁶Rheumatology, Sanatorio Adventista del Plata, Entre Rios, Argentina, ²⁷Sanatorio Pasteur, Catamarca, Argentina, ²⁸Hospital de Niños Dr Orlando Alasia, Santa Fé, Argentina, ²⁹Ramallo 1851, REUMAR, CABA, Argentina, ³⁰Consultorio, Cordoba, Argentina, ³¹Hospital de Rehabilitación Rocca, CABA, Argentina, ³²Atención Integral de Reumatología, CABA, Argentina, ³³CEIM, CABA, Argentina, ³⁴Hospital de Niños de Córdoba, Córdoba, Argentina, ³⁵Centro Raquis, Buenos Aires, Argentina, ³⁶Hospital Fernandez, CABA, Argentina, ³⁷SOMMA, Buenos Aires, Argentina, ³⁸Hospital Pirovano, CABA, Argentina, ³⁹Centro Médico Mitre, Entre Rios, Argentina, ⁴⁰IARI, CABA, Argentina, ⁴¹Sanatorio Británico, Rosario, Argentina
Background/Purpose: Biologic therapies (bDMARDs) have improved the treatment of rheumatic diseases; however, the risk of herpes zoster (HZ) virus infection or reactivation in patients treated…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].